Drug Development Consulting Holding ApS — Credit Rating and Financial Key Figures

Drug Development Consulting Holding ApS (CVR number: 42285722K) is a company from ALBERTSLUND. The company recorded a gross profit of 141.6 mDKK in 2023. The operating profit was -9194.4 kDKK, while net earnings were -9376.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -4.2 %, which can be considered poor and Return on Equity (ROE) was -13.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 39.9 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Drug Development Consulting Holding ApS's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.